Cryoprecipitate (Native)
Indications: - Coagulation defects, purpura or other haemorrhagic or related conditions - Obstetric haemorrhage - Haemophilia A - Von Willebrand disease Source: EML workbook import

Browse procurement-ready healthcare products from trusted vendors across the Afya Chain marketplace.
Indications: - Coagulation defects, purpura or other haemorrhagic or related conditions - Obstetric haemorrhage - Haemophilia A - Von Willebrand disease Source: EML workbook import
Formulations: - Injection: frozen liquid in bag or lyophilized powder in vial containing: > 50 IU Factor VIII > 100 IU vWF > 140 mg clottable fibrinogen per unit Indications: - Coagulation defects, purpura or other haemorrhagic or related conditions - Obstetric haemorrhage - Haemophilia A - Von Willebrand disease Source: EML workbook import
Formulations: - Parenteral > General injections > IV: Indications: - Blood transfusion without reported diagnosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: Indications: - Blood transfusion without reported diagnosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: Indications: - Blood transfusion without reported diagnosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: Indications: - Blood transfusion without reported diagnosis Source: EML workbook import
Indications: - Coagulation defects, purpura or other haemorrhagic or related conditions - Haemophilia B Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 500 IU in vial powder for injection; 1000 IU in vial powder for injection Indications: - Haemophilia B Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 250 IU per mL in vial lyophilized powder for solution for injection; 500 IU in vial lyophilized powder for solution for injection; 1000 IU in vial lyophilized powder for solution for injection; 1500 IU in vial lyophilized powder for solution for injection; 2000 IU in vial lyophilized powder for solution for injection; 3000 IU in vial lyophilized powder for solution for injection; 4000 IU in vial lyophilized powder for solution for injection Indications: - Haemophilia B Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 250 IU in vial powder for injection; 500 IU in vial powder for injection; 1000 IU in vial powder for injection Indications: - Haemophilia A Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 250 IU in vial lyophilized powder for solution for injection; 500 IU in vial lyophilized powder for solution for injection; 1000 IU in vial lyophilized powder for solution for injection; 1500 IU in vial lyophilized powder for solution for injection; 2000 IU in vial lyophilized powder for solution for injection; 3000 IU in vial lyophilized powder for solution for injection; 4000 IU in vial lyophilized powder for solution for injection Indications: - Haemophilia A Source: EML workbook import
Formulations: - Oral > Solid > tablet: 100 mg (chewable); 500 mg (chewable) Indications: - Other specified echinococcosis - Ascariasis - Enterobiasis - Trichuriasis - Hookworm diseases Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.